New diagnostic test for human African Sleeping Sickness

September 12, 2017 by Roddy Isles
Credit: University of Dundee

A new diagnostic test developed from research at the Universities of Dundee and Cambridge has been launched with the aim of helping eliminate the disease known as African sleeping sickness.

Sleeping sickness, or Human African Trypanosomiasis (HAT), is caused by parasites transmitted by tsetse flies in sub-Saharan Africa and has a devastating impact, causing thousands of deaths each year.

Today, September 12th, the international non-profit organisation FIND and the diagnostics company Alere launched their second-generation rapid diagnostic (RDT) for sleeping sickness. This second-generation test is easier and safer to produce, using recombinant protein technology to produce the two diagnostic antigens, one of which is completely new.

The new test, SD BIOLINE HAT 2.0, costs US $0.50 each and requires no specialist equipment to diagnose sleeping sickness from a pin-prick of blood, providing the same level of accuracy but in a more robust production format.

The test has been developed from research performed in the laboratories of Professor Mike Ferguson at Dundee and Professor Mark Carrington at Cambridge, with device prototyping done at BBI Solutions in the Dundee Technology Park.

"This is a terrible disease that causes character disintegration, psychological deterioration followed by coma and death, and current treatments are far from ideal," said Professor Carrington.

"The World Health Organisation's goal is to eliminate HAT and rapid and accurate diagnosis is essential to achieving this objective. It is extremely encouraging for us as researchers to see our work now being deployed in the field where it can make a real difference to people."

The work at Dundee and Cambridge was supported through separate funding streams from the Wellcome Trust and the Medical Research Council (MRC).

Both the Dundee and Cambridge labs were supported by the Wellcome Trust at the time the research was done, and much of the work was performed by Dr Lauren Sullivan, MRC PhD student and then MRC Centenary fellow between 2008 and 2013, and Dr Mandy Crow, MRC PhD student between 2000 and 2004.

Professor Ferguson said, "Sometimes impactful comes from side-projects where one synthesises funding streams, in this case from the MRC and the Wellcome Trust, and works across institutions and with industrial partners to do something more speculative or applied. The science underpinning this new diagnostic device is a good case in point."

Explore further: Scientists discover sleeping sickness can also be transmitted and spread via the skin

More information: For more from FIND see: www.finddx.org/news/alere-find … -gen-hat-rapid-test/

Related Stories

Scientists discover sleeping sickness can also be transmitted and spread via the skin

September 23, 2016
Scientists have made an important new discovery in the study of Human African Trypanosomiasis, more commonly known as African sleeping sickness. The findings could have a major impact on the way the disease is diagnosed, ...

Rapid 'dipstick' test tackles fatal sleeping sickness

December 15, 2015
Scientists have developed a quick and simple diagnosis method, similar to a dipstick pregnancy test, to fight a deadly sleeping sickness.

Silencing signals sent by parasite could aid sleeping sickness fight

December 15, 2013
A new discovery by scientists could help combat the spread of sleeping sickness.

New blood test developed to tackle major livestock disease in Africa

September 12, 2016
The University of Dundee and the Global Alliance for Livestock Veterinary Medicines (GALVmed) have partnered to develop a simple and effective device that tests for a cattle disease that is endemic in 40 African countries ...

Recommended for you

Groundbreaking investigative effort identifies gonorrhea vaccine candidates

September 19, 2017
Researchers at Oregon State University have identified a pair of proteins that show promise as the basis for a gonorrhea vaccine.

Snail fever progression linked to nitric oxide production

September 14, 2017
Bilharzia, caused by a parasitic worm found in freshwater called Schistosoma, infects around 200 million people globally and its advance can lead to death, especially in children in developing countries.

Systems analysis points to links between Toxoplasma infection and common brain diseases

September 13, 2017
More than 2 billion people - nearly one out of every three humans on earth, including about 60 million people in the United States - have a lifelong infection with the brain-dwelling parasite Toxoplasma gondii.

Study clears important hurdle toward developing an HIV vaccine

September 13, 2017
An international team of researchers has demonstrated a way of overcoming one of the major stumbling blocks that has prevented the development of a vaccine against HIV: the ability to generate immune cells that stay in circulation ...

As 'flesh-eating' Leishmania come closer, a vaccine against them does, too

September 13, 2017
Parasites that ulcerate the skin, can disfigure the face, and may fatally mutilate its victim's internal organs are creeping closer to the southern edges of the United States.

Promising clinical trial results could give doctors a new tool against drug-resistant strains of malaria parasite

September 13, 2017
Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published in the latest issue of The Lancet Infectious ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.